ConvaTec Group PLC (LON:CTEC) Receives GBX 306 Consensus PT from Brokerages

Shares of ConvaTec Group PLC (LON:CTEC) have earned a consensus recommendation of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 306.

CTEC has been the subject of several research analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 315 target price on shares of ConvaTec Group in a research report on Monday, August 3rd. JPMorgan Chase & Co. reduced their price target on shares of ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating on the stock in a research report on Friday, May 22nd. UBS Group reissued a “buy” rating and issued a GBX 375 price target on shares of ConvaTec Group in a research note on Monday, May 18th. Peel Hunt reaffirmed an “add” rating and set a GBX 270 price objective on shares of ConvaTec Group in a research report on Tuesday, August 4th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday, August 5th.

Insider Buying and Selling at ConvaTec Group

In other news, insider Jonny Mason acquired 50,000 shares of the stock in a transaction on Tuesday, May 26th. The stock was acquired at an average price of GBX 201 per share, with a total value of £100,500. Also, insider Tobias Hestler bought 50,000 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were acquired at an average price of GBX 226 per share, for a total transaction of £113,000. 0.98% of the stock is owned by corporate insiders.

ConvaTec Group Stock Performance

LON:CTEC opened at GBX 236 on Friday. The stock has a market cap of £4.61 billion, a P/E ratio of 27.44, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. The firm’s fifty day simple moving average is GBX 214.99 and its 200 day simple moving average is GBX 221.02. ConvaTec Group has a twelve month low of GBX 193 and a twelve month high of GBX 259.30. The company has a quick ratio of 0.96, a current ratio of 1.93 and a debt-to-equity ratio of 121.83.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.